Vitamin E supplements may slow coronary artery disease progression -- JAMA study.
This article was originally published in The Tan Sheet
Executive Summary
VITAMIN E SUPPLEMENTATION MAY SLOW PROGRESSION OF CORONARY ARTERY DISEASE, a subgroup analysis of the data-base acquired in the Cholesterol Lowering Atherosclerosis Study (CLAS) suggests. CLAS was a randomized, placebo-controlled, serial angiographic clinical trial designed to evaluate the effect of cholesterol-lowering agents colestipol and niacin on coronary artery disease progression. The study, supported by the National Heart, Lung and Blood Institute, was published in the June 21 Journal of the American Medical Association.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning